ARTICLE | Clinical News
BC-819 regulatory update
September 28, 2015 7:00 AM UTC
FDA granted Fast Track designation to BioCancell’s BC-819 to treat bladder cancer. Next half, the company plans to start 2 Phase III trials of the plasmid encoding diphtheria toxin to treat non-muscle...